Loblaw Companies Limited (TSE:L – Get Free Report) has been given a consensus rating of “Moderate Buy” by the six brokerages that are currently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is C$191.29.
L has been the topic of a number of recent research reports. CIBC boosted their price objective on Loblaw Companies from C$189.00 to C$206.00 in a research note on Thursday, November 14th. BMO Capital Markets upped their price target on Loblaw Companies from C$160.00 to C$180.00 in a report on Friday, July 26th. Royal Bank of Canada increased their price objective on shares of Loblaw Companies from C$183.00 to C$205.00 in a research report on Tuesday, November 12th. TD Securities reduced their target price on shares of Loblaw Companies from C$203.00 to C$202.00 and set a “buy” rating on the stock in a research report on Thursday, November 14th. Finally, National Bankshares raised their price target on shares of Loblaw Companies from C$188.00 to C$195.00 in a report on Thursday, November 14th.
Loblaw Companies Stock Performance
Loblaw Companies Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Monday, December 30th. Shareholders of record on Sunday, December 15th will be issued a $0.513 dividend. This represents a $2.05 dividend on an annualized basis and a yield of 1.15%. Loblaw Companies’s dividend payout ratio is currently 31.06%.
Loblaw Companies Company Profile
Loblaw Companies Limited, a food and pharmacy company, provides grocery, pharmacy and healthcare services, health and beauty products, apparels, general merchandise, financial services, and wireless mobile products and services in Canada. It operates in two segments, Retail and Financial Services. The Retail segment operates corporate and franchise-owned retail food, and associate-owned drug stores.
Featured Stories
- Five stocks we like better than Loblaw Companies
- Trading Stocks: RSI and Why it’s Useful
- Tesla Investors Continue to Profit From the Trump Trade
- Business Services Stocks Investing
- MicroStrategy’s Stock Dip vs. Coinbase’s Potential Rally
- What Are Dividend Achievers? An Introduction
- Netflix Ventures Into Live Sports, Driving Stock Momentum
Receive News & Ratings for Loblaw Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Loblaw Companies and related companies with MarketBeat.com's FREE daily email newsletter.